ArticleBMC public health2025
Investigating the relationship between social stigma and treatment adherence in type 2 diabetes patients at healthcare centers in Northwest Iran.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reframing diabetes mellitus care in South Africa through lived experience, peer support and advocacy: Lessons from the 2025 Diabetes Summit.African journal of primary health care & family medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe social stigma associated with type 2 diabetes is a significant global mental and social health issue that can hinder treatment adherence among patients. To address this concern, the present study aimed to examine the relationship between social stigma and treatment adherence levels in type 2 diabetes patients attending healthcare centers in northwest Iran.
methodsIn this descriptive-correlation study, 432 patients with type 2 diabetes referred to Ardabil city health service centers were selected by simple random and multi-stage cluster method. The data collection tools included the personal-social profile form, type 2 diabetes stigma assessment scale (DSAS-2), and treatment adherence questionnaire. Data were analyzed using SPSS 26 software with descriptive statistics, independent t-tests, analysis of variance, a logistic linear regression model.
resultsThe results indicated that the average score for the total social stigma of type 2 diabetes among the studied samples was 59.27 ± 15.52. A high level of perceived social stigma was observed in 55.6% of the patients. The average score for treatment adherence was 97.46 ± 28.79, with an adherence situation at an average level (59.7%). An inverse relationship was identified between the social stigma of diabetes and adherence to treatment (r = -0.29, p < 0.001). Additionally, there was a significant relationship between the average score of social stigma of diabetes and variables such as gender and marital status, as well as between the average score of treatment adherence and the gender of patients. The stepwise multiple linear regression model revealed that 15.1% of the variance in treatment adherence could be explained by age, duration of the disease, and social stigma of diabetes.
conclusionThe study found that, more than half of the patients had social stigma and reported their adherence to treatment as moderate. Also, there was an inverse and significant correlation between social stigma and treatment adherence. Therefore, it is necessary to provide psychological counseling services to reduce social stigma and teach the importance of adherence to treatment in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.